AME Study of [14C]-ETC-1002 in Healthy Male Volunteers (QBR116553)

• Research type

  Research Study

• Full title

  A Phase 1, Open-Label, Single-Radiolabeled Dose Study to Investigate the Absorption, Metabolism and Excretion of [14C]-ETC-1002 in Healthy Male Volunteers

• IRAS ID

  140157

• Contact name

  Stuart Mair

• Contact email

  stuart.mair@quotientclinical.com

• Sponsor organisation

  Esperion Therapeutics, Inc.

• Eudract number

  2013-003852-19

• REC name

  HSC REC B

• REC reference

  13/NI/0170

• Date of REC Opinion

  22 Oct 2013

• REC opinion

  Favourable Opinion